申请人:PROVOST FELLOWS & SCHOLARS COLLEGE OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
公开号:WO2013026852A2
公开(公告)日:2013-02-28
Mecamylamine is a general nicotinic acetylcholine receptor (nAChR) antagonist that was one of the first anti-hypertensive agents. Since its demise as an anti-hypertensive drug, mecamylamine has been shown to aid smoking cessation (in humans), reduce cue induced craving in human cocaine addicts and heavy drinkers. The present invention provides for novel derivatives of mecamylamine and inventive synthetic routes to these compounds.